Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza seasonKAMADA, Makoto; NAGAI, Takao; TORIGOE, Sadayoshi et al.Vaccine. 2006, Vol 24, Num 17, pp 3618-3623, issn 0264-410X, 6 p.Article

Long-term clinical trial safety experience with the inactivated split influenza vaccine, Vaxigrip®DELORE, Valentine; SALAMAND, Camille; MARSH, Grenville et al.Vaccine. 2006, Vol 24, Num 10, pp 1586-1592, issn 0264-410X, 7 p.Article

Oculorespiratory syndrome after influenza immunization in childrenSKOWRONSKI, Danuta M; BJORNSON, Gordean; HUSAIN, Entesar et al.The Pediatric infectious disease journal. 2005, Vol 24, Num 1, pp 63-69, issn 0891-3668, 7 p.Article

Adverse events after Fluzone^® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011―2013MORO, Pedro L; HARRINGTON, Theresa; SHIMABUKURO, Tom et al.Vaccine. 2013, Vol 31, Num 43, pp 4984-4987, issn 0264-410X, 4 p.Article

Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip : an inactivated split virion influenza vaccine -supports wider vaccine useAMOUX, Sabine; WEINBERGER, Clement; GESSNER, Bradford D et al.Vaccine. 2007, Vol 25, Num 45, pp 7720-7731, issn 0264-410X, 12 p.Article

Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosisATO, Manabu; TAKAHASHI, Yoshimasa; FUJII, Hideki et al.Vaccine. 2013, Vol 31, Num 17, pp 2184-2190, issn 0264-410X, 7 p.Article

An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccineLEE, Yoon-Sook; LEE, Kyoo-A; LEE, Jae-Young et al.Vaccine. 2011, Vol 29, Num 3, pp 417-425, issn 0264-410X, 9 p.Article

Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccinationOHMIT, Suzanne E; GROSS, Jonathan; VICTOR, John C et al.Vaccine. 2009, Vol 27, Num 7, pp 1050-1054, issn 0264-410X, 5 p.Article

Trends in US pediatric influenza vaccination from 2006 to 2010 among children with private insuranceTOBACK, Seth L; HERLEY, John; EDELMAN, Laurel et al.Vaccine. 2011, Vol 29, Num 25, pp 4225-4229, issn 0264-410X, 5 p.Article

Seasonal inactivated influenza virus vaccinesCOUCH, Robert B.Vaccine. Supplement. 2008, Vol 26, Num 4, issn 1359-5938, D5-D9Article

The evolving history of influenza viruses and influenza vaccinesHANNOUN, Claude.Expert review of vaccines. 2013, Vol 12, Num 9, pp 1085-1094, issn 1476-0584, 10 p.Article

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network : Results from the 2005-2006 season of dual A and B vaccine mismatch in CanadaSKOWRONSKI, D. M; MASARO, C; KWINDT, T. L et al.Vaccine. 2007, Vol 25, Num 15, pp 2842-2851, issn 0264-410X, 10 p.Article

Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged >65 yearsSCHWARZ, Tino F; SCHMOELE-THOMA, Beate.Vaccine. 2013, Vol 31, Num 2, pp 291-294, issn 0264-410X, 4 p.Article

The Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Children as a Function of Time PostvaccinationAMBROSE, Christopher S; XIONGHUA WU; BELSHE, Robert B et al.The Pediatric infectious disease journal. 2010, Vol 29, Num 9, pp 806-811, issn 0891-3668, 6 p.Article

Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humansCOUCH, Robert B; ATMAR, Robert L; CATE, Thomas R et al.Vaccine. 2009, Vol 27, Num 39, pp 5344-5348, issn 0264-410X, 5 p.Article

Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccineJONES, Jeremy C; SETTLES, Erik W; BRANDT, Curtis R et al.Vaccine. 2011, Vol 29, Num 44, pp 7696-7703, issn 0264-410X, 8 p.Article

A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and olderFORREST, Bruce D; DUNCAN STEELE, A; HIEMSTRA, Louis et al.Vaccine. 2011, Vol 29, Num 20, pp 3633-3639, issn 0264-410X, 7 p.Article

Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: A case―control studyJOSHI, Avni Y; IYER, Vivek N; SAUVER, Jennifer L. St et al.Vaccine. 2009, Vol 27, Num 33, pp 4457-4461, issn 0264-410X, 5 p.Article

A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 yearsTENNIS, Patricia; TOBACK, Seth L; ANDREWS, Elizabeth et al.Vaccine. 2011, Vol 29, Num 31, pp 4947-4952, issn 0264-410X, 6 p.Article

Effectiveness of Intranasal Live Attenuated Influenza Vaccine Against All-cause Acute Otitis Media in ChildrenHEIKKINEN, Terho; BLOCK, Stan L; TOBACK, Seth L et al.The Pediatric infectious disease journal. 2013, Vol 32, Num 6, pp 669-674, issn 0891-3668, 6 p.Article

Recommendations for Prevention and Control of Influenza in Children, 2012―2013Pediatrics (Evanston). 2012, Vol 130, Num 4, pp 780-793, issn 0031-4005, 14 p.Article

The Efficacy of Live Attenuated Influenza Vaccine Against Influenza-associated Acute Otitis Media in ChildrenBLOCK, Stan L; HEIKKINEN, Terho; TOBACK, Seth L et al.The Pediatric infectious disease journal. 2011, Vol 30, Num 3, pp 203-207, issn 0891-3668, 5 p.Article

Prevention of Influenza : Recommendations for Influenza Immunization of Children, 2008-2009Pediatrics (Evanston). 2008, Vol 122, Num 5, pp 1135-1141, issn 0031-4005, 7 p.Article

Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United StatesLUCE, Bryan R; NICHOL, Kristin L; BELSHE, Robert B et al.Vaccine. 2008, Vol 26, Num 23, pp 2841-2848, issn 0264-410X, 8 p.Article

Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfectionOKAMOTO, Shigefumi; KAWABATA, Shigetada; FUJITAKA, Hideaki et al.Vaccine. 2004, Vol 22, Num 21-22, pp 2887-2893, issn 0264-410X, 7 p.Article